MAPT and Alzheimer disease: However, the hypothesis has limitations; clinicaltrials targeting Aβ have not successfully treated AD, suggesting other factors are likely involved [7].The tau hypothesis postulates that the buildup of abnormal tau proteins in the brain is the primary causal factor in the development ofAD, rather than Aβ [8].